152 related articles for article (PubMed ID: 22185025)
1. [Lozartan potential in hyperuricemia correction].
Ter Arkh; 2011; 83(10):45-8. PubMed ID: 22185025
[TBL] [Abstract][Full Text] [Related]
2. Uric acid: role in cardiovascular disease and effects of losartan.
Alderman M; Aiyer KJ
Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
[TBL] [Abstract][Full Text] [Related]
3. [Other antihyperuricemic agents].
Ogino K; Igawa O; Hisatome I
Nihon Rinsho; 2008 Apr; 66(4):754-7. PubMed ID: 18409527
[TBL] [Abstract][Full Text] [Related]
4. [Serum uric acid--a cardiovasular risk factor?].
Alderman M; Redfern JS
Ther Umsch; 2004 Sep; 61(9):547-52. PubMed ID: 15493113
[TBL] [Abstract][Full Text] [Related]
5. To study the efficacy of Losartan on urinary uric acid excretion in Thiazide induced hyperuricemic and hypertensive patients.
Khan M; Khan RA; Islam F; Laghari J; Jamali SN
Pak J Pharm Sci; 2011 Oct; 24(4):583-7. PubMed ID: 21959825
[TBL] [Abstract][Full Text] [Related]
6. Effect of Antihypertensive Drugs on Uric Acid Metabolism in Patients with Hypertension: Cross-Sectional Cohort Study.
Ueno S; Hamada T; Taniguchi S; Ohtani N; Miyazaki S; Mizuta E; Ohtahara A; Ogino K; Yoshida A; Kuwabara M; Yoshida K; Ninomiya H; Kotake H; Taufiq F; Yamamoto K; Hisatome I
Drug Res (Stuttg); 2016 Dec; 66(12):628-632. PubMed ID: 27643410
[No Abstract] [Full Text] [Related]
7. Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics.
Rayner BL; Trinder YA; Baines D; Isaacs S; Opie LH
Am J Hypertens; 2006 Feb; 19(2):208-13. PubMed ID: 16448895
[TBL] [Abstract][Full Text] [Related]
8. Which is a better treatment for hypertensive patients with diabetes: a combination of losartan and hydrochlorothiazide or a maximum dose of losartan?
Nishimura H; Shintani M; Maeda K; Otoshi K; Fukuda M; Okuda J; Nishi S; Ohashi S; Kato S; Baba Y;
Clin Exp Hypertens; 2013; 35(8):582-8. PubMed ID: 23496265
[TBL] [Abstract][Full Text] [Related]
9. Losartan vs. amlodipine treatment in elderly oncologic hypertensive patients: a randomized clinical trial.
Motta M; Russo C; Vacante M; Liardo RL; Reitano F; Cammalleri L; Costanzo M; Benfatto G; Frazzetto P; Mondati E; Malaguarnera M; Pennisi G
Arch Gerontol Geriatr; 2011; 53(1):60-3. PubMed ID: 20569998
[TBL] [Abstract][Full Text] [Related]
10. Losartan treatment for hypertensive patients with hyperuricaemia in Chinese population: a meta-analysis.
Fan Y; Wei F; Lang Y; Wang S
J Hypertens; 2015 Apr; 33(4):681-8; discussion 689. PubMed ID: 25915869
[TBL] [Abstract][Full Text] [Related]
11. [Drug-induced hypouricemia: pathophysiology and application to the hyperuricemia with life style related disease].
Hisatome I; Ogino K; Igawa O; Shigemasa C
Nihon Rinsho; 2003 Jan; 61 Suppl 1():403-9. PubMed ID: 12629757
[No Abstract] [Full Text] [Related]
12. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and gout.
Liberopoulos E; Christides D; Elisaf M
J Hypertens; 2002 Feb; 20(2):347. PubMed ID: 11821722
[No Abstract] [Full Text] [Related]
13. [The pleiotropic effects of losartan--the importance of decreasing uric acid level].
Csiky B; Markó L; Mohás M; Cseh J; Mikolás E; Szíjártó I; Wittmann I
Lege Artis Med; 2008 Oct; 18(10):663-6. PubMed ID: 19227608
[TBL] [Abstract][Full Text] [Related]
14. [Hyperuricemia in hypertension: any clinical implication?].
Deléaval P; Burnier M
Rev Med Suisse; 2005 Sep; 1(32):2072-4, 2077-9. PubMed ID: 16238227
[TBL] [Abstract][Full Text] [Related]
15. [New perspectives of the use of angiotensin II receptor blocker].
Sidorenko BA; Ugriumova MO
Kardiologiia; 2003; 43(6):88-96. PubMed ID: 13677329
[No Abstract] [Full Text] [Related]
16. Hyperuricemia, cardiovascular disease, and the metabolic syndrome.
Indraratna PL; Williams KM; Graham GG; Day RO
J Rheumatol; 2009 Dec; 36(12):2842-3; author reply 2844. PubMed ID: 19966196
[No Abstract] [Full Text] [Related]
17. [Uric acid--more deleterious than we thought?].
Høieggen A; Os I; Kjeldsen SE
Tidsskr Nor Laegeforen; 2005 May; 125(10):1330-2. PubMed ID: 15909004
[TBL] [Abstract][Full Text] [Related]
18. AT1 blockers and uric acid metabolism: are there relevant differences?
Puig JG; Torres R; Ruilope LM
J Hypertens Suppl; 2002 Jun; 20(5):S29-31. PubMed ID: 12184060
[TBL] [Abstract][Full Text] [Related]
19. The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome.
Simão AN; Lozovoy MA; Dichi I
Expert Opin Ther Targets; 2012 Dec; 16(12):1175-87. PubMed ID: 23020656
[TBL] [Abstract][Full Text] [Related]
20. URAT1 gene polymorphisms influence uricosuric action of losartan in hypertensive patients with hyperuricemia.
Sun H; Qu Q; Qu J; Lou XY; Peng Y; Zeng Y; Wang G
Pharmacogenomics; 2015 Jul; 16(8):855-63. PubMed ID: 26086348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
